Antibody targeting CD38 enzyme shows positive impact in treating systemic sclerosis
Elevated expression of NAD+-consuming enzymes in fibrotic pores and skin. Credit score: Scientific Reviews (2023). DOI: 10.1038/s41598-023-49450-1 Scleroderma is a ...